
Glimu M 1mg/500mg Tablet SR
Marketer
Grapple Life Sciences Pvt Ltd
Salt Composition
Glimepiride (1mg) + Metformin (500mg)
Overview Glimu M 1mg/500mg Tablet SR
Metformin/Glibenclamide 1mg/500mg extended-release tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by regulating blood glucose. Administer this medication with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication complements a comprehensive diabetes management plan encompassing a balanced diet, regular exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a common side effect. Learn to identify symptoms like sweating, dizziness, headache, and tremors, and know how to treat them. Consistent meals and carrying a fast-acting glucose source (e.g., sugary snacks or juice) are preventative measures. Alcohol consumption elevates hypoglycemia risk and should be limited. Other potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver disease. Individuals with a history of heart disease should inform their physician before commencing treatment. Pregnant or breastfeeding women require medical consultation prior to use. Regular blood glucose monitoring and periodic blood tests to assess blood cell counts and liver function are recommended.
Uses of Glimu M 1mg/500mg Tablet SR
Managing type 2 diabetes
Major Benefits of Glimu M 1mg/500mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glimu M 1mg/500mg Tablet SR whole; avoid chewing, crushing, or breaking it. Administer this extended-release tablet with a meal.
Common Side effects of Glimu M 1mg/500mg Tablet SR:
- Headache
- Hypoglycemia (low blood glucose level)
- Nausea
- Diarrhea
How to use Glimu M 1mg/500mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glimu M 1mg/500mg Tablet SR whole; avoid chewing, crushing, or breaking it. Administer this medication with a meal.
How Glimu M 1mg/500mg Tablet SR works:
Glimu M 1mg/500mg Extended-Release tablets contain glimepiride and metformin, two agents that manage blood sugar. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol and Glimu M 1mg/500mg SR tablet use poses a safety risk.
PregnancyCONSULT YOUR DOCTOR
The use of Glimu M 1mg/500mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any possible risks prior to prescription. Patient consultation with their doctor is advised.
Breast feedingUNSAFE
Extended-release Glimu M 1mg/500mg tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant harm from this medication.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Exercise caution when administering Glimu M 1mg/500mg Tablet SR to individuals with impaired kidney function; dosage modification may be necessary. Severe kidney disease contraindicates the use of Glimu M 1mg/500mg Tablet SR. Physician consultation is recommended. Routine monitoring of renal function is advised during treatment.
LiverCAUTION
Exercise caution when administering Glimu M 1mg/500mg SR tablets to individuals with hepatic impairment. Dosage modification of Glimu M 1mg/500mg SR tablets may be necessary. Physician consultation is advised. For patients exhibiting mild to moderate liver dysfunction, initiate Glimu M 1mg/500mg SR tablets at a reduced dosage; its use is contraindicated in those with severe liver disease.
What if you forget to take Glimu M 1mg/500mg Tablet SR :
Should you forget a Glimu M 1mg/500mg SR Tablet dose, take it immediately if feasible. Otherwise, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Glimu M 1mg/500mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
